Women with a type of ovarian cancer that is very difficult to treat have shown remarkable results on a clinical trial testing a new combination of drugs.Almost a third (31%) of women with low-grade serous ovarian cancer,

Scientists say the Royal Marsden hospitals' drug trial could change practice globally for serous form of ovarian cancer which doesn't respond well to chemotherapy

A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ovarian cancer that rarely responds to chemotherapy or hormone therapy.

A new combination of drugs is offering hope to women with a type of ovarian cancer that is very difficult to treat after a successful clinical trial. Tumours shrank or stopped growing in almost one in three women (31 per cent) with low-grade serous ovarian cancer,

Almost a third of women with low-grade serous ovarian cancer, which does not respond well to chemotherapy, saw their tumours shrink or stop growing with the drugs